The global 22q11.2 deletion syndrome therapeutics market is experiencing a period of significant growth, driven by factors such as increasing understanding of the condition and the development of novel medicinal approaches . Scientists are actively investigating a broad range of therapeutic options , including gene therapy, pharmacological therapie